XENE (STOCKS)
Xenon Pharmaceuticals Inc
$58.600000
+0.200000 (+0.34%)
Prev close: $58.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ian C. Mortimer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,591.08M
- Employees
- 327
- P/E (TTM)
- -13.44
- P/B (TTM)
- 8.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
11
Strong Buy
14
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.31 | $-1.22 | -0.0947 | -7.79% |
|
Sep 2025 (Q3)
|
$-1.15 | $-1.18 | +0.0250 | +2.13% |
|
Jun 2025 (Q2)
|
$-1.07 | $-1.01 | -0.0589 | -5.83% |
|
Mar 2025 (Q1)
|
$-0.83 | $-0.93 | +0.1000 | +10.75% |
Financial Statements
| Revenues | $7.50M |
| Benefits Costs and Expenses | $352.39M |
| Costs And Expenses | $352.39M |
| Nonoperating Income/Loss | $28.18M |
| Operating Expenses | $380.57M |
| Depreciation and Amortization | $2.54M |
| Research and Development | $300.94M |
| Other Operating Expenses | $77.09M |
| Operating Income/Loss | -$373.07M |
| Income/Loss From Continuing Operations After Tax | -$345.91M |
| Income/Loss From Continuing Operations Before Tax | -$344.89M |
| Income Tax Expense/Benefit | $1.02M |
| Income Tax Expense/Benefit, Current | $4.21M |
| Income Tax Expense/Benefit, Deferred | -$3.20M |
| Net Income/Loss | -$345.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$345.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$345.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.36 |
| Diluted Earnings Per Share | -$4.36 |
| Basic Average Shares | 79,253,751 |
| Diluted Average Shares | 79,253,751 |
| Assets | $633.16M |
| Current Assets | $560.65M |
| Noncurrent Assets | $72.51M |
| Fixed Assets | $8.72M |
| Non-current Prepaid Expenses | $7.15M |
| Other Non-current Assets | $56.64M |
| Liabilities | $51.40M |
| Current Liabilities | $41.79M |
| Wages | $14.46M |
| Other Current Liabilities | $27.33M |
| Noncurrent Liabilities | $9.61M |
| Equity | $581.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $581.76M |
| Liabilities And Equity | $633.16M |
| Net Cash Flow From Operating Activities | -$279.12M |
| Net Cash Flow From Operating Activities, Continuing | -$279.12M |
| Net Cash Flow From Investing Activities | $218.00M |
| Net Cash Flow From Investing Activities, Continuing | $218.00M |
| Net Cash Flow From Financing Activities | $117.11M |
| Net Cash Flow From Financing Activities, Continuing | $117.11M |
| Exchange Gains/Losses | $458.00K |
| Net Cash Flow | $56.45M |
| Net Cash Flow, Continuing | $55.99M |
| Comprehensive Income/Loss | -$343.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$343.96M |
| Other Comprehensive Income/Loss | $1.95M |